Odyssey Therapeutics Inc.
ODTX | NASDAQ
$19.31
-$0.23 (-1.18%)
Nov 2, 2026, 12:52 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 |
|---|---|---|
PE Ratio | -7.34 | -20.27 |
PEG Ratio | -0.06 | n/a |
PS Ratio | n/a | n/a |
PB Ratio | 1.34 | -1.48 |
P/FCF Ratio | -7.47 | -18.81 |
P/OCF Ratio | -7.50 | -18.88 |
OCF/S Ratio | n/a | n/a |
Debt / Equity Ratio | 0.06 | -0.05 |
Quick Ratio | 11.36 | 8.33 |
Current Ratio | 11.36 | 8.33 |
Asset Turnover | n/a | n/a |
Interest Coverage | -2.77K | -3.98K |
Return on Equity | -12.53% | 7.31% |
Return on Assets | -10.91% | -16.70% |
Return on Invested Capital | -12.03% | -18.74% |
Dividend Yield | n/a | n/a |
Payout Ratio | n/a | n/a |
FCF Payout Ratio | n/a | n/a |
Gross Profit Margin | n/a | n/a |
Net Profit Margin | n/a | n/a |
Pretax Profit Margin | n/a | n/a |
Operating Profit Margin | n/a | n/a |
FCF Margin | n/a | n/a |
EBITDA Margin | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove ODTX